Alexandra Barbelivien
Papers
1
Total Citations
19
H-Index
1
About
Alexandra Barbelivien is a neuroscientist whose research centers on the neurobiology of cognition and the development of molecular imaging tools for brain disorders. Her most cited work, the 1998 study "Synthesis and biological investigations of [18F]MR18445, a 5-HT3 receptor partial agonist," with 19 citations, represents a foundational contribution to the design of radiotracers for positron emission tomography (PET). This research targeted the 5-HT3 serotonin receptor, a key player in anxiety, depression, and cognitive function, and provided a novel partial agonist for in vivo imaging—a critical step toward understanding serotonergic signaling in health and disease. Barbelivien’s impact lies in bridging medicinal chemistry and behavioral neuroscience, enabling non-invasive exploration of neurotransmitter systems. Her work has informed subsequent studies on receptor pharmacology and neuropsychiatric conditions, and she is recognized for advancing the synthesis of selective radioligands. With a career dedicated to unraveling the molecular underpinnings of cognition, Barbelivien continues to influence the field of neuroimaging, offering tools that help researchers visualize and quantify brain function in living subjects.
Research Focus
Key Achievements
Top Papers
- 1